Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 18Leukemia, Myeloid, Acute 12Myelodysplastic Syndromes 10Lymphoma 10Burkitt Lymphoma 8Graft vs Host Disease 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Lymphocytic, Chronic, B-Cell 6Blast Crisis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pdgfra-Associated Chronic Eosinophilic Leukemia 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Non-Hodgkin 5Leukemia, Neutrophilic, Chronic 5Congenital Abnormalities 5Thrombocythemia, Essential 4Primary Myelofibrosis 4Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Biphenotypic, Acute 4Hodgkin Disease 4Hematologic Neoplasms 4Neoplasms, Plasma Cell 3

Interventions

Ifosfamide 2Doxorubicin 2selinexor 1seclidemstat 1pazopanib 1Topotecan 1Sunitinib 1Proton Therapy 1Nivolumab 1Methotrexate 1HhAntag691 1Epirubicin 1Dacarbazine 1Cyclophosphamide 1Cisplatin 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Chondrosarcoma, Extraskeletal Myxoid × Methotrexate × Clear all
NCT03277924 2024-08-13

ImmunoSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Completed
197 enrolled
Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡